Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
Clinical trial NCT01465347 · COMPLETED
Trial details
- NCT number
- NCT01465347
- Sponsor
- Diffusion Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2015-11-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.